What analyst predict for Johnson & Johnson NYSE:JNJ ?
Johnson & Johnson NYSE:JNJ
Johnson & Johnson is stock market daily expected to report earnings on 04/17/2018 before market open. The report will be for the fiscal Quarter ending Mar 2018. According to Investment Research, based on 9 analysts’ forecasts, the consensus EPS forecast for the quarter is $2.01. The reported EPS for the same quarter last year was $1.83.
Overview of Johnson & Johnson NYSE:JNJ
Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace innovation—bringing ideas, products and services to life to advance the health and well-being of people around the world. We believe in collaboration, and that has led to breakthrough after breakthrough, from medical miracles that have changed lives, to the simple consumer products that make every day a little better. Our over 125,000 employees in 60 countries are united in a common mission: To help people everywhere live longer, healthier, happier lives.
The Johnson & Johnson Family of Consumer Companies offers the world’s largest range of consumer healthcare products. Our baby care, skin care, oral care, wound care, over-the-counter and women’s health products feature brands trusted by consumers and healthcare professionals worldwide. By anticipating needs and creating solutions and experiences, we help people live healthy, vibrant lives.
|% Change from 52 Week Low|
|% Change from 52 Week High|